Botox vs Dysport Units: Conversion Guide

A Botox-to-Dysport calculator can give you a number, but it can't promise the same result. One Botox unit isn't equal to one Dysport unit, and the final outcome depends on much more than the quantity recorded in a treatment plan. Product-specific potency assays, dilution, injection volume, muscle strength, facial anatomy, needle placement, and the injector's understanding of movement all shape the result.

In practice, clinicians commonly use approximately 2.5 to 3 Dysport units for each 1 Botox unit, although published comparisons have reported ratios from 1:2.67 to 1:4 depending on the indication and study design (Cochrane clinical review). That makes the ratio useful as a planning reference, not as a promise of biological equivalence.

Treatment considerationBotox, onabotulinumtoxinADysport, abobotulinumtoxinA
Unit relationshipOne product-specific unitApproximately 2.5 to 3 units for each Botox unit in common clinical planning
Unit interchangeabilityNot interchangeable with DysportNot interchangeable with Botox
Common practical rolePrecise, localized dosingBroader treatment planning when appropriate
What changes the resultMuscle anatomy, dose, dilution, placement, techniqueMuscle anatomy, dose, dilution, placement, technique
Most useful price comparisonCost per treated areaCost per treated area, not cost per unit

Table of Contents

Why Simple Unit Calculators Mislead Patients

The most popular advice about Botox vs Dysport units is also the most incomplete: multiply the Botox number by a fixed ratio and assume the treatment will behave identically. That approach is convenient, but it treats a clinical decision as if it were a currency conversion.

A unit is a manufacturer-specific measurement created through a particular potency assay. It isn't a universal biological standard that transfers cleanly between products. Reviews commonly place the practical relationship near 2.5 to 3 Dysport units for each Botox unit, while other analyses report a wider range influenced by the treatment indication, injection method, and study design (comparative clinical review).

The number is only one variable

Suppose a patient has a strong corrugator complex and a noticeable difference in brow height between the two sides. The injector may not apply a ratio to the previous Botox dose. They'll assess which muscles are creating the movement, how much movement should remain, and whether equal dosing on both sides would produce symmetry.

Reconstitution matters, too. The same total number of labeled units can be prepared in different volumes, changing how much liquid is delivered at each injection point. A larger volume may influence the treatment field, while a smaller volume can support more concentrated placement. Neither approach is automatically superior. The appropriate choice depends on the area and the injector's plan.

For patients comparing treatment prices, this guide to Botox cost per unit is useful only if you remember that a Botox unit and a Dysport unit aren't equivalent billing or potency units. Compare the total cost for the treated area and the treatment plan, not the advertised price attached to one unit.

Practical rule: A conversion chart can help you ask informed questions, but it shouldn't replace an examination of your facial movement and anatomy.

The Regulatory History Behind Dosing Differences

Botox and Dysport did not emerge from one shared dosing system. Their separate development paths shaped their labels, vial sizes, and unit definitions. For patients, that history explains why a unit on one product cannot be substituted directly for a unit on the other.

Dysport's therapeutic history began earlier in Europe. It received marketing authorization for dystonias in December 1990, then gained U.S. approval for cervical dystonia in 2009, before its broader cosmetic use (regulatory history review). Those indications involved different muscles, treatment goals, and dose ranges from aesthetic injections, so their labeled numbers do not translate neatly to forehead, glabellar, or crow's-feet treatment.

A timeline graphic showing the regulatory history and the FDA approval dates for Botox and Dysport products.

Separate labels created separate dosing habits

In the United States, Botox is supplied in 50-, 100-, and 200-unit vials, while Dysport is supplied in 300- and 500-unit vials. The larger Dysport vial does not mean the product is weaker, just as the smaller Botox vial does not make it stronger. Vial size reflects each product's assay, development history, approved indications, and labeling conventions.

Dysport labeling generally calls for treatment intervals of at least 12 weeks. Some approved therapeutic indications use single-treatment doses from 250 to 1000 units, while doses above 1000 units were not systematically evaluated in that labeling context. These figures describe therapeutic use, not a cosmetic prescription.

The practical distinctions are clear:

  • Different assays: Each manufacturer measures potency through its own testing system.
  • Different vial sizes: Packaging reflects different clinical applications and dosing conventions.
  • Different labeling: Approved doses depend on the indication, muscle group, and treatment objective.
  • No 1:1 substitution: A labeled number on one product does not represent the same biological amount on another.

Regulatory history explains why conversion charts exist. It also shows their limits. The final treatment plan still depends on muscle anatomy, dilution, injection placement, and the movement the injector intends to preserve.

Analyzing the Clinical Conversion Ratios

A conversion chart can suggest a starting point, but it cannot prescribe an aesthetic treatment. In controlled studies of cervical dystonia, approximately 1 Botox unit corresponds to about 3 Dysport units, with reported comparisons ranging from 2.5:1 to 4:1 depending on the indication and study design (randomized clinical trial). These findings support a practical benchmark, not a universal formula for every forehead, glabella, or crow's-feet treatment.

The clinical question is whether the selected dose relaxes the intended muscle while preserving the movement and expression the patient wants. A study comparing Botox at its labeled clinical dose with Dysport at three times that dose found similar improvement and no significant safety difference. That result makes 3:1 a useful reference point, while still leaving room for adjustment based on anatomy, muscle strength, treatment goals, and prior response.

What potency studies add

Potency testing explains why different ratios appear in the literature. A randomized dose-ranging volunteer study estimated bioequivalence at 1.57 Dysport units per 1 Botox unit, with a 95% confidence interval from 0.77 to 3.20. The investigators found that a 3:1 ratio remained within statistical error, while higher ratios were too aggressive (dose-ranging potency study).

The reported product-content potency values were 137 units per nanogram for Botox and 154 units per nanogram for Dysport for the 150 kD neurotoxin component. Those findings reinforce a practical rule: labeled units are assay-specific measurements, not universal biological units.

MetricBotox, onabotulinumtoxinADysport, abobotulinumtoxinA
Common clinical benchmark1 unitApproximately 2.5 to 3 units
Broader reported comparison rangeReference productApproximately 2.67 to 4 units in some studies
Volunteer-study estimateReference point1.57 units, with a 95% confidence interval of 0.77 to 3.20
Product-content potency reported for 150 kD component137 units per nanogram154 units per nanogram
Clinical interpretationProduct-specific unitProduct-specific unit, not a direct substitute

Translating evidence to an individual face

Study averages do not determine an individual patient's result. The glabella may require a different plan from the forehead because the muscles, desired movement, and consequences of excessive weakening differ. A calculator can suggest an initial range, but the injector must still decide how much product to use and where to place it to preserve brow position and balanced expression.

For that reason, 2.5:1 to 3:1 is a conversation starter, not a guarantee. A provider should ask about previous treatment response, muscle strength, the treatment area, and the patient's aesthetic goals before presenting a conversion. The unit count matters, but dilution, injection volume, placement, and anatomy determine how that count behaves in the face.

Understanding Diffusion and Injector Technique

Patients often ask whether Dysport “spreads more” than Botox. The honest answer is that the evidence is mixed, and the observed treatment field depends on dose, dilution, injection volume, placement, and the study model, not solely on the brand name.

Diffusion describes how the injected material moves through nearby tissue. Efficacy describes whether the targeted muscle relaxes enough to produce the desired result. Duration describes how long that effect remains clinically useful. These concepts overlap in a patient's experience, but they aren't interchangeable.

A professional nurse in a lab coat and blue gloves preparing a syringe from a medical vial.

How technique changes the treatment field

An injector controls several practical variables:

  1. Dilution and volume: The amount of liquid used to reconstitute the vial affects the volume delivered at each point. Unit count alone doesn't tell you how much liquid entered the tissue.
  2. Injection placement: A superficial injection, a deeper injection, and a placement near the edge of a muscle can produce different patterns of effect.
  3. Point distribution: More treatment points can distribute the dose across a wider muscle, while fewer points may concentrate delivery.
  4. Anatomical mapping: The injector must identify active muscles, asymmetries, brow support, eyelid position, and the patient's resting expression before selecting sites.

A broader field of effect can be helpful across a large, flat area, but it can be undesirable near structures where small changes matter. A localized approach may support precision, but it can leave uneven activity if the injector doesn't account for the full muscle pattern.

The product doesn't create natural results by itself. The injector earns natural results through dose selection, placement, and restraint.

What patients should ask

Instead of asking only, “Which one spreads more?” ask how the provider will manage spread for your specific anatomy. Useful questions include:

  • How will you adjust the dilution for this treatment area?
  • Which muscles are you treating, and which muscles are you intentionally preserving?
  • How will you address asymmetry?
  • When will you assess the final result?
  • What would make you choose a lower or higher dose than a standard conversion?

Those questions reveal whether the provider is thinking beyond the syringe label. A slightly broader effect doesn't automatically mean better wrinkle correction, longer duration, or more side effects. The clinical objective is controlled muscle relaxation, not maximum spread.

Real-World Dosing for Common Treatment Areas

A conversion ratio becomes more useful when it's placed inside an anatomical plan. The same Botox-to-Dysport relationship can produce different decisions in the glabella, forehead, and crow's feet because each area has different muscle size, strength, movement patterns, and tolerance for excess weakening.

The examples below use a 1:2.5 planning ratio, which is a commonly cited practical benchmark. They're not prescriptions. A provider may adjust the amount, injection pattern, or product choice after assessing your facial movement.

A comparison chart showing the different unit doses of Botox and Dysport for common facial treatment areas.

Glabella

The glabella, or the area between the brows, contains several muscles that create vertical frown lines and downward brow movement. A common comparison uses 20 Botox units versus 50 Dysport units, based on the 1:2.5 benchmark shown in the treatment comparison graphic.

But a patient with a stronger corrugator on one side may not need identical placement on both sides. The provider may preserve some movement to avoid a flat or heavy expression, particularly if the brow is already low or the upper eyelid feels heavy.

Forehead

The frontalis lifts the brows and spans the forehead, so treating horizontal lines requires more attention to support than smoothing every visible crease. A practical comparison uses 10 to 15 Botox units versus 25 to 37.5 Dysport units for forehead lines at the same planning ratio.

A cautious injector may use less than a calculator suggests if the patient relies heavily on the frontalis to keep the brows raised. The goal is softer lines while preserving a balanced brow position, not complete immobility.

Crow's feet

Crow's feet involve the circular muscle around the eyes, where precision matters because the treatment sits near the eyelid and smile mechanics. A common comparison uses 12 Botox units per side versus 30 Dysport units per side at a 1:2.5 ratio.

The treatment plan may change if the patient's smile is asymmetric, if the lines extend farther than expected, or if preserving strong lateral eye movement is a priority. A provider who treats every face with the same point pattern can miss those differences.

For patients considering Dysport specifically, the Dysport treatment information at ProMD Health Tysons Corner can be a starting point before an in-person assessment. The consultation remains the point where a generalized comparison becomes an individualized plan.

Evaluating Safety, Duration, and Treatment Value

A unit count cannot establish safety or value on its own. Patient selection, product handling, dilution, injection depth, placement, muscle anatomy, and follow-up timing all affect the result. A larger number on the syringe may reflect formulation differences, not a stronger or better treatment.

Treatment intervals should generally allow the previous session to show its full effect before another session is considered. For Dysport, labeled therapeutic dosing can range from 250 to 1000 units for some indications, with doses above 1000 units not systematically evaluated in that context, as noted in the Dysport prescribing information review. These figures apply to labeled therapeutic indications. They are not a cosmetic conversion target, and they should not replace an examination of muscle activity and treatment goals.

Value is measured per treatment area

Dysport uses a larger numerical unit count because its units cannot be exchanged directly for Botox units. A lower listed price per Dysport unit may therefore produce a similar or higher total treatment cost, while a higher Botox price per unit does not automatically mean greater value.

Ask the clinic to explain:

  • Total treatment price: What is the complete cost for the planned area?
  • Dose rationale: How do muscle strength, anatomy, and movement support the proposed amount?
  • Dilution and placement: How will preparation and injection technique affect control and spread?
  • Follow-up policy: When will the provider assess the response?
  • Maintenance planning: How will the clinic avoid unnecessary early retreatment?
  • Product tracking: Which formulation and batch information will be documented?

Duration varies by individual, muscle group, dose, placement, and prior treatment response. If one product seems to wear off sooner, automatically increasing the dose may miss the underlying issue. The injector should first review the treatment pattern, muscle activity, and whether the original goal was appropriate.

Potential adverse effects are summarized in this Botox treatment side effects guide. Seek prompt medical attention for unexpected difficulty swallowing, speaking, or breathing after treatment, even though serious reactions are uncommon. A sound treatment plan balances visible improvement with preserved expression and controlled retreatment.

Choosing the Right Provider for Natural Results

The most important choice isn't whether the syringe contains Botox or Dysport. It's whether the provider can read your facial anatomy and control the treatment accordingly.

A qualified injector should assess your resting expression, active muscle movement, brow position, eyelid support, asymmetry, skin quality, and previous treatment response. They should also explain what they're choosing not to treat. Natural results often come from preserving selected movement, not from weakening every muscle that creates a line.

What a thoughtful consultation includes

Look for a practice that:

  • Examines movement: The provider watches you raise your brows, frown, smile, squint, and relax your face.
  • Explains conversion carefully: The provider treats the ratio as an estimate rather than a promise.
  • Documents the plan: Product, areas, injection points, and response are recorded for future refinement.
  • Discusses restraint: The provider explains how they'll reduce the risk of heaviness, asymmetry, or unwanted weakness.
  • Uses visualization appropriately: ProMD Health Tysons Corner offers the Entity Med AI Simulator, which can help patients preview personalized potential outcomes and set realistic expectations before treatment.

Screenshot from https://promdtysonscorner.com

A skilled provider can achieve attractive results with either product because the treatment is built around anatomy, not branding. If your consultation focuses only on a low per-unit price or a rigid conversion chart, you're missing the variables that have the greatest influence on the final look.


ProMD Health Tysons Corner provides personalized Botox and Dysport consultations, with treatment planning based on your facial anatomy, goals, timeline, and comfort rather than a fixed calculator. Visit ProMD Health Tysons Corner to schedule a complimentary consultation and discuss which neuromodulator approach fits your features.